TCL Archive Fidaxomicin for CDI Therapy More Cost-Effective Than Vancomycin, Study Says September 26, 2014
TCL Archive Two Groups Take Different Approaches To Managing Toxicity Of Saltz Regimen. June 22, 2001
TCL Archive In Brief: ACS Massachusetts Div. Offers $1,500 Grants To Improve community Hospital Cancer Care March 2, 1979